论文部分内容阅读
目的:评价银杏达莫注射液与甲钴胺联用对糖尿病周围神经病变患者的临床疗效。方法:选取2012年8月—2014年8月间收治的糖尿病神经病变患者80例,将其分为观察组和对照组,每组40例;对照组患者均给予甲钴胺治疗,观察组患者在对照组基础上再给予银杏达莫注射液治疗,比较两组患者的临床疗效。结果:经治疗,观察组患者临床治疗的总有效率为87.50%明显高于对照组为80.00%(P<0.05);治疗后观察组患者的神经传导速度明显快于对照组患者(P<0.05)。结论:银杏达莫注射液与甲钴胺联用治疗糖尿病周围神经病变患者的临床疗效和安全性均优于单用甲钴胺治疗。
Objective: To evaluate the clinical efficacy of gingko Damo injection combined with mecobalamin in patients with diabetic peripheral neuropathy. Methods: Eighty patients with diabetic neuropathy admitted from August 2012 to August 2014 were divided into observation group and control group, 40 cases in each group. Patients in the control group were treated with mecobalamin. The patients in the observation group On the basis of the control group, ginkgo dipyridamole injection was given again to compare the clinical efficacy of the two groups. Results: After treatment, the total effective rate of clinical treatment in observation group was 87.50%, which was significantly higher than that in control group (80.00%, P <0.05); the nerve conduction velocity in observation group was significantly faster than that in control group after treatment ). Conclusion: The clinical efficacy and safety of ginkgo dipyridamole injection combined with mecobalamin in the treatment of diabetic peripheral neuropathy are better than mecobalamin alone.